Industry Focus

Biotech's biggest stories this year include trial data and FDA decisions for therapies targeting indications with a massive need for new treatment options, including blood disorders, genetic diseases, and Alzheimer's Disease. Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts. Stocks: BIIB, BLUE, GBT, AIMT, DBVT, VRTX, SRPT Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter